JP2025507864A - 操作された細胞および使用方法 - Google Patents

操作された細胞および使用方法 Download PDF

Info

Publication number
JP2025507864A
JP2025507864A JP2024552028A JP2024552028A JP2025507864A JP 2025507864 A JP2025507864 A JP 2025507864A JP 2024552028 A JP2024552028 A JP 2024552028A JP 2024552028 A JP2024552028 A JP 2024552028A JP 2025507864 A JP2025507864 A JP 2025507864A
Authority
JP
Japan
Prior art keywords
cell
cells
protein
promoter region
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024552028A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025507864A5 (cg-RX-API-DMAC10.html
Inventor
ゲイ エム. クルックス
ドナルド ビー. コーン
サン ピル ヨ
パトリック チャン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California, San Diego
Original Assignee
University of California, San Diego
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, San Diego filed Critical University of California, San Diego
Publication of JP2025507864A publication Critical patent/JP2025507864A/ja
Publication of JP2025507864A5 publication Critical patent/JP2025507864A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
    • A61K40/31—Chimeric antigen receptors [CAR]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4202—Receptors, cell surface antigens or cell surface determinants
    • A61K40/421—Immunoglobulin superfamily
    • A61K40/4211—CD19 or B4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/50—Cellular immunotherapy characterised by the use of allogeneic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2024552028A 2022-03-02 2023-03-02 操作された細胞および使用方法 Pending JP2025507864A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202263315579P 2022-03-02 2022-03-02
US202263315581P 2022-03-02 2022-03-02
US63/315,581 2022-03-02
US63/315,579 2022-03-02
US202363442966P 2023-02-02 2023-02-02
US63/442,966 2023-02-02
PCT/US2023/063587 WO2023168341A1 (en) 2022-03-02 2023-03-02 Engineered cells and methods of use

Publications (2)

Publication Number Publication Date
JP2025507864A true JP2025507864A (ja) 2025-03-21
JP2025507864A5 JP2025507864A5 (cg-RX-API-DMAC10.html) 2026-03-09

Family

ID=87884252

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024552028A Pending JP2025507864A (ja) 2022-03-02 2023-03-02 操作された細胞および使用方法

Country Status (6)

Country Link
EP (1) EP4486870A4 (cg-RX-API-DMAC10.html)
JP (1) JP2025507864A (cg-RX-API-DMAC10.html)
CN (1) CN119137262A (cg-RX-API-DMAC10.html)
AU (1) AU2023227880A1 (cg-RX-API-DMAC10.html)
CA (1) CA3253740A1 (cg-RX-API-DMAC10.html)
WO (1) WO2023168341A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117030580B (zh) * 2023-09-15 2024-07-16 广州市第一人民医院(广州消化疾病中心、广州医科大学附属市一人民医院、华南理工大学附属第二医院) LDNs在坏死性小肠结肠炎诊断中的应用
WO2026123001A2 (en) * 2024-12-06 2026-06-11 Umoja Biopharma, Inc. Lineage-loci engineered cell therapy and related methods of producing and using same
WO2026133125A1 (en) * 2024-12-16 2026-06-25 Janssen Biotech, Inc. T cell-specific promoters and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0716570A4 (en) * 1993-09-03 1997-12-17 Systemix Inc Genetically Modified Human Hematopoietic Stem Cells and Their Offspring
AU2018301667A1 (en) * 2017-07-12 2020-02-06 Fundação D. Anna De Sommer Champalimaud E Dr. Carlos Montez Champalimaud Foundation Methods and systems for conditionally regulating gene expression
EP4171616A1 (en) * 2020-06-26 2023-05-03 Juno Therapeutics GmbH Engineered t cells conditionally expressing a recombinant receptor, related polynucleotides and methods

Also Published As

Publication number Publication date
WO2023168341A1 (en) 2023-09-07
EP4486870A1 (en) 2025-01-08
CA3253740A1 (en) 2023-09-07
AU2023227880A1 (en) 2024-10-17
EP4486870A4 (en) 2026-05-20
CN119137262A (zh) 2024-12-13

Similar Documents

Publication Publication Date Title
AU2023202195B2 (en) Methods of generating T-cells from stem cells and immunotherapeutic methods using the T-cells
JP7580726B2 (ja) 操作されたオフザシェルフ免疫細胞およびそれらの使用方法
AU2019287483B2 (en) Stem cell-engineered iNKT cell-based off-the-shelf cellular therapy
EP4486870A1 (en) Engineered cells and methods of use
WO2024102707A1 (en) Methods and compositions for generating immune cells from progenitor cells
WO2025208050A2 (en) Engineered mucosal-associated invariant t (mait) cells and methods of making and using thereof
EP4735581A2 (en) Methods of making and using engineered immune cells
WO2023224923A2 (en) Engineered cells and methods of use
JP2026506126A (ja) 既製の細胞療法のための多能性幹細胞操作免疫細胞
WO2025054202A1 (en) Method of screening a sample comprising a transgene with a unique barcode
EA048607B1 (ru) Способы получения т-клеток из стволовых клеток и иммунотерапевтические способы применения т-клеток

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20260227

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20260227

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20260723